TET2 and lymphoma: The data from mouse model demonstrated that RHOA (G17V) cooperates with TCR stimulation to promote TFH-cell expansion, and lymphoma development in the presence of TET2 loss-of function [42, 44], suggesting the possibility of a functional interaction between these genetic alterations leading to a predilection for TFH phenotype.